Search Results - "Azarnoff, D L"

Refine Results
  1. 1

    Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers by DYCK, J. B, MAZE, M, HAACK, C, AZARNOFF, D. L, VUORILEHTO, L, SHAFER, S. L

    Published in Anesthesiology (Philadelphia) (01-05-1993)
    “…This investigation extended the pharmacokinetic analysis of our previous study, of intravenous dexmedetomidine in 10 healthy male volunteers, and prospectively…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humans by Angst, Martin S., Dyck, John B., Azarnoff, Daniel L., Goldblum, Ronald, Ho, Bert, Gfroerer, Thomas, Linton, Elizabeth A., Glynn, Brendan P., Shafer, Steven L.

    Published in Clinical pharmacology and therapeutics (01-11-1998)
    “…Objective Two clinical trials investigated the pharmacokinetics of human corticotropin‐releasing factor (hCRF), resulting cortisol release, and associated…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effect of portacaval shunt on the disposition of drugs with and without first-pass effect by Gugler, R, Lain, P, Azarnoff, D L

    “…The pharmacokinetic parameters of lidocaine, antipyrine and salicylamide were studied in dogs before and after construction of a portacaval shunt. The systemic…”
    Get more information
    Journal Article
  6. 6

    Diphenylhydantoin potency and plasma protein binding by Shoeman, D W, Azarnoff, D L

    “…Rats were given diphenylhydantoin (DPH) orally, and its potency in protecting against maximal electroshock seizures was determined. The effect of an…”
    Get more information
    Journal Article
  7. 7

    Topical Application of Lindane Cream (Kwell) and Antipyrine Metabolism by Hosler, James, Tschanz, Christian, Hignite, Charles E., Azarnoff, Daniel L.

    Published in Journal of investigative dermatology (01-01-1980)
    “…The transcutaneous absorption of a 1% lindane cream (Kwell) was determined after application according to the official label. By 3days after application the…”
    Get full text
    Journal Article
  8. 8

    Quantitation of N-demethylantipyrine in biological samples and isolation and characterization of its glucuronic acid conjugate by Hignite, C E, Tschanz, C, Huffman, D H, Azarnoff, D L

    Published in Drug metabolism and disposition (01-05-1978)
    “…An improved method for quantitating N-demethylantipyrine (N-DEM-AP) in urine by gas chromatography or gas chromatography-mass spectrometry has been developed…”
    Get more information
    Journal Article
  9. 9

    Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents by Moody, D E, Reddy, J K, Azarnoff, D L

    Published in Biochemical pharmacology (15-08-1984)
    “…Xenobiotic induction of liver peroxisomes is associated with hypolipidemia. To test the involvement of the peroxisome proliferation with the hypolipidemia,…”
    Get more information
    Journal Article
  10. 10

    Nafenopin-Induced Hepatic Microbody (Peroxisome) Proliferation and Catalase Synthesis in Rats and Mice: Absence of Sex Difference in Response by Reddy, Jarnardan K., Azarnoff, Daniel L., Svoboda, Donald J., Prasad, Jada D.

    Published in The Journal of cell biology (01-05-1974)
    “…Nafenopin (2-methyl-2[p-(1,2,3,4-tetrahydro-1-naphthyl)phenoxy]-propionic acid; Su-13437), a potent hypolipidemic compound, was administered in varying…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Methapyrilene kinetics and dynamics by Calandre, E P, Alferez, N, Hassanein, K, Azarnoff, D L

    Published in Clinical pharmacology and therapeutics (01-04-1981)
    “…A study was undertaken to characterize the H1 receptor blockade, central nervous system depressant properties, and kinetic parameters of methapyrilene in man…”
    Get more information
    Journal Article
  14. 14

    Metabolic responses to plasma concentrations of theophylline by Cathcart-Rake, W F, Kyner, J L, Azarnoff, D L

    Published in Clinical pharmacology and therapeutics (01-07-1979)
    “…We investigated the effect of intravenous infusions of aminophylline on plasma glucose, insulin (IRI), glucagon (IRG), growth hormone (HGH), cortisol, and free…”
    Get more information
    Journal Article
  15. 15

    The effect of concurrent oral administration of propranolol and disopyramide on cardiac function in healthy men by Cathcart-Rake, W F, Coker, J E, Atkins, F L, Huffman, D H, Hassanein, K M, Shen, D D, Azarnoff, D L

    Published in Circulation (New York, N.Y.) (01-05-1980)
    “…Sixteen healthy men were evaluated for left ventricular performance changes and beta-blockade after therapeutic oral doses of disopyramide and propranolol…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20